D-dimer is a soluble fibrin degradation product deriving from the plasmin-mediated
degradation of cross-linked fibrin. D-dimer can hence be considered a biomarker of …

ABSTRACT D-dimers are formed by the breakdown of fibrinogen and fibrin during
fibrinolysis. D-dimer analysis is critical for the diagnosis of deep vein thrombosis, pulmonary …

Background: Post‐thrombotic syndrome (PTS) occurs in 20–50% of patients after a deep
venous thrombosis (DVT). It is difficult to accurately predict which patients will develop PTS …

Background: The prevalence of pulmonary embolism (PE) in patients presenting with
syncope to the emergency department (ED) is largely unknown. This information, however …

D-dimer containing species are soluble fibrin degradation products derived from plasmin-
mediated degradation of cross-linked fibrin, ie,'D-dimer'. D-dimer can hence be considered a …

Object The incidence of deep venous thrombosis (DVT) after craniotomy is reported to be as
high as 50%. In outpatients, D-dimer levels of more than 0.5 mg/L indicate venous …

Background Obstructive sleep apnea (OSA) and insomnia are frequent sleep problems that
are associated with poor prognosis in patients with coronary heart disease. The …

Background A prothrombotic tendency could partially explain the poor prognosis of patients
with coronary heart disease and depression. We hypothesized that cognitive depressive …

D-dimer is a multifaceted biomarker of concomitant activation of coagulation and fibrinolysis,
which is routinely used for ruling out pulmonary embolism (PE) and/or deep vein thrombosis …

In a general population with acute Pulmonary Embolism (PE) elevated D-dimer
concentrations associate with increased mortality. The aim of the study was to assess the …